Literature DB >> 8097570

Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.

C J Wiedermann1, N Reinisch, M Niedermühlbichler, H Braunsteiner.   

Abstract

Growth hormone, prolactin and somatostatin are polypeptide hormones of the neuroendocrine and peripheral nervous systems. In vitro, these have opposing effects on cells of the immune system. We compared the effects of these peptides on activation of neutrophils using a recombinant preparation of human growth hormone, human prolactin and octreotide, a long acting analog of somatostatin. In the absence of growth hormone, octreotide did not affect either neutrophil locomotion or respiratory burst. Octreotide, however, significantly antagonized growth hormone-induced activation of neutrophils for enhanced respiratory burst as well as growth hormone-induced inhibition of stimulated migration. As the effect of growth hormone on neutrophils is mediated by the prolactin receptor, its inhibition by octreotide was also tested using prolactin as priming agent. Data indicate comparable effects of octreotide on priming of neutrophils by prolactin. The effect of octreotide was dose-dependent and appeared to be selective, as activation of neutrophil respiration burst by gamma-interferon, and inhibition of stimulated migration by tumor necrosis factor-alpha were unaffected by octreotide. The present study suggests that octreotide may act on neutrophils directly by antagonizing growth hormone or prolactin at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097570     DOI: 10.1007/bf00167454

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

Review 1.  Growth hormone, lymphocytes and macrophages.

Authors:  K W Kelley
Journal:  Biochem Pharmacol       Date:  1989-03-01       Impact factor: 5.858

2.  A defect in chemotaxis from interleukin-2.

Authors:  B Schleiffenbaum; R Moser; J Fehr
Journal:  N Engl J Med       Date:  1990-09-06       Impact factor: 91.245

3.  Somatropin and wound healing after injury.

Authors:  H J Belcher; H Ellis
Journal:  J Clin Endocrinol Metab       Date:  1990-04       Impact factor: 5.958

Review 4.  Neutrophil activation by recombinant cytokines.

Authors:  M J Steinbeck; J A Roth
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

Review 6.  Oncological applications of somatostatin analogues.

Authors:  A V Schally
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

7.  Opiate receptor-mediated chemotaxis of human monocytes.

Authors:  M R Ruff; S M Wahl; S Mergenhagen; C B Pert
Journal:  Neuropeptides       Date:  1985-02       Impact factor: 3.286

8.  Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action.

Authors:  O Serri; P Brazeau; Z Kachra; B Posner
Journal:  Endocrinology       Date:  1992-04       Impact factor: 4.736

Review 9.  Shared recognition molecules in the brain and lymphoid tissues: the polypeptide mediator network of psychoneuroimmunology.

Authors:  C J Wiedermann
Journal:  Immunol Lett       Date:  1987-12       Impact factor: 3.685

10.  Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.

Authors:  Y H Atkinson; W A Marasco; A F Lopez; M A Vadas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

View more
  3 in total

1.  Characterization of the priming effect by pituitary canine growth hormone on canine polymorphonuclear neutrophil granulocyte function.

Authors:  T K Petersen; C W Smith; A L Jensen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Nitric oxide and octreotide in retinal ischemia-reperfusion injury.

Authors:  Ulku Celiker; Necip Ilhan
Journal:  Doc Ophthalmol       Date:  2002-11       Impact factor: 2.379

3.  Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.

Authors:  M Kilian; J I Gregor; I Heukamp; K Helmecke; M Hanel; B Wassersleben; M K Walz; I Schimke; G Kristiansen; F A Wenger
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.